Molecules 2000, 5(2), 99-113; doi:10.3390/50200099

Novel Coumarin Derivatives with Expected Biological Activity

Therapeutical Chemistry Department, National Research Centre, Dokki, Cairo, Egypt
* Author to whom correspondence should be addressed.
Received: 13 August 1999; Accepted: 20 October 1999 / Published: 16 February 2000
PDF Full-text Download PDF Full-Text [101 KB, uploaded 6 October 2008 15:45 CEST]
Abstract: A number of novel 3-bromo-4-methyl-7-methoxy-8-amino substituted coumarins and 2-substituted 7-bromo-6-methyl-8H-pyrano-benzimidazoles, benzoxazoles and/or benzoxazine-8-ones were synthesized for the purpose of pharmacological evaluation. Some representative compounds showed antitumor activity in vitro on Ehrlich ascites carcinoma in the preliminary testing.
Keywords: Substituted coumarins; nitro reduction; benzylidinyl amino coumarins

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Nofal, Z.M.; El-Zahar, M.I.; Abd El-Karim, S.S. Novel Coumarin Derivatives with Expected Biological Activity. Molecules 2000, 5, 99-113.

AMA Style

Nofal ZM, El-Zahar MI, Abd El-Karim SS. Novel Coumarin Derivatives with Expected Biological Activity. Molecules. 2000; 5(2):99-113.

Chicago/Turabian Style

Nofal, Z. M.; El-Zahar, M. I.; Abd El-Karim, S. S. 2000. "Novel Coumarin Derivatives with Expected Biological Activity." Molecules 5, no. 2: 99-113.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert